Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, Larson MC, Maurer MJ, Slager S, Macon WR, King RL, Feldman AL, Gandhi AK, Link BK, Habermann TM, Yang ZZ, Ansell SM, Cerhan JR, Witzig TE, Nowakowski GS, Novak AJ. Hartert KT, et al. Among authors: sarangi v. Leukemia. 2021 Feb;35(2):522-533. doi: 10.1038/s41375-020-0766-4. Epub 2020 Mar 5. Leukemia. 2021. PMID: 32139889 Free PMC article. Clinical Trial.
PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data.
Wang C, Evans JM, Bhagwate AV, Prodduturi N, Sarangi V, Middha M, Sicotte H, Vedell PT, Hart SN, Oliver GR, Kocher JP, Maurer MJ, Novak AJ, Slager SL, Cerhan JR, Asmann YW. Wang C, et al. Among authors: sarangi v. Bioinformatics. 2014 Sep 15;30(18):2678-80. doi: 10.1093/bioinformatics/btu363. Epub 2014 May 29. Bioinformatics. 2014. PMID: 24876377 Free PMC article.
Genetic diversity of newly diagnosed follicular lymphoma.
Asmann YW, Maurer MJ, Wang C, Sarangi V, Ansell SM, Feldman AL, Nowakowski GS, Manske M, Price-Troska T, Yang ZZ, Slager SL, Habermann TM, Cerhan JR, Novak AJ. Asmann YW, et al. Among authors: sarangi v. Blood Cancer J. 2014 Oct 31;4(10):e256. doi: 10.1038/bcj.2014.80. Blood Cancer J. 2014. PMID: 25360902 Free PMC article. No abstract available.
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.
Davila JI, Starr JS, Attia S, Wang C, Knudson RA, Necela BM, Sarangi V, Sun Z, Ren Y, Casler JD, Menke DM, Oliver GR, Joseph RW, Copland JA, Parker AS, Kocher JA, Thompson EA, Smallridge RC, Asmann YW. Davila JI, et al. Among authors: sarangi v. Rare Tumors. 2017 Sep 15;9(2):6834. doi: 10.4081/rt.2017.6834. eCollection 2017 Jul 3. Rare Tumors. 2017. PMID: 28975018 Free PMC article.
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma.
Wenzl K, Manske MK, Sarangi V, Asmann YW, Greipp PT, Schoon HR, Braggio E, Maurer MJ, Feldman AL, Witzig TE, Slager SL, Ansell SM, Cerhan JR, Novak AJ. Wenzl K, et al. Among authors: sarangi v. Blood Cancer J. 2018 Oct 9;8(10):97. doi: 10.1038/s41408-018-0130-3. Blood Cancer J. 2018. PMID: 30301877 Free PMC article.
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.
Wang Y, Habermann TM, Wang SS, Maurer MJ, Sarangi V, Link BK, Feldman AL, Inwards DJ, Witzig TE, Cozen W, Rothman N, Asmann Y, Slager SL, Cerhan JR. Wang Y, et al. Among authors: sarangi v. Am J Hematol. 2019 Jun;94(6):E153-E155. doi: 10.1002/ajh.25451. Epub 2019 Mar 15. Am J Hematol. 2019. PMID: 30815899 Free PMC article. No abstract available.
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
Wang Y, Wenzl K, Manske MK, Asmann YW, Sarangi V, Greipp PT, Krull JE, Hartert K, He R, Feldman AL, Maurer MJ, Slager SL, Nowakowski GS, Habermann TM, Witzig TE, Link BK, Ansell SM, Cerhan JR, Novak AJ. Wang Y, et al. Among authors: sarangi v. Blood Cancer J. 2019 Aug 30;9(9):73. doi: 10.1038/s41408-019-0233-5. Blood Cancer J. 2019. PMID: 31471540 Free PMC article.
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.
Kleinstern G, Yan H, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, Purdue MP, Vajdic CM, Vermeulen RCH, Giles GG, Cocco PL, Birmann BM, Kraft P, Albanes D, Zeleniuch-Jacquotte A, Crouch S, Zhang Y, Sarangi V, Asmann Y, Offit K, Salles G, Wu X, Smedby KE, Skibola CF, Slager SL, Rothman N, Chanock SJ, Cerhan JR. Kleinstern G, et al. Among authors: sarangi v. Hum Mol Genet. 2020 Jan 1;29(1):70-79. doi: 10.1093/hmg/ddz228. Hum Mol Genet. 2020. PMID: 31600786 Free PMC article.
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Krull JE, Wenzl K, Hartert KT, Manske MK, Sarangi V, Maurer MJ, Larson MC, Nowakowski GS, Ansell SM, McPhail E, Habermann TM, Link BK, King RL, Cerhan JR, Novak AJ. Krull JE, et al. Among authors: sarangi v. Blood Cancer J. 2020 Nov 9;10(11):117. doi: 10.1038/s41408-020-00382-3. Blood Cancer J. 2020. PMID: 33168821 Free PMC article. Clinical Trial.
41 results